External validation of a clinical pharmacy intervention in geriatric inpatients: a controlled study.
Belgium
Clinical pharmacy
External validation
Minimal intervention
Older inpatients
Polypharmacy
Potentially inappropriate medication
Journal
International journal of clinical pharmacy
ISSN: 2210-7711
Titre abrégé: Int J Clin Pharm
Pays: Netherlands
ID NLM: 101554912
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
27
06
2018
accepted:
09
05
2019
pubmed:
17
5
2019
medline:
21
1
2020
entrez:
17
5
2019
Statut:
ppublish
Résumé
Background Clinical pharmacist interventions have been shown to improve drug use in older adults. Study findings are seldom externally validated however. Objective First, to validate a minimized iteration of a previously tested intervention of clinical pharmacists in a non-academic setting with limited staffing resources. Second, to compare the potentially inappropriate medication (PIM) reduction to two previous controlled interventional studies. Methods A controlled study was performed at geriatric wards. The control group received usual care. The intervention group was exposed to a clinical pharmacist led medication review, based on the use of the RASP list, (the Rationalization of Home Medication by an Adjusted STOPP list in Older Patients). Drug use on admission and at discharge were evaluated, including the number of RASP-identified potentially inappropriate medications (PIMs). The PIM reduction was compared to two previous controlled study findings using a linear mixed model. Results Drug use declined during hospital stay, without differences between control (n = 29) and intervention group (n = 32). Antidepressants and hypnotic drugs were discontinued more frequently in IG patients. More PIMs were reduced in the intervention patients (control vs. intervention: 1.0 vs. 3.0, p < 0.001). Across three controlled studies, a robust reduction of 1.56 PIMs (95% confidence interval 1.10-2.02, p < 0.001) was observed in favor of the CP interventions. Conclusion The minimal CP intervention resulted in fewer RASP PIMs. No net reduction of drug use was observed, yet fewer antidepressants and hypnotic drugs were used. The RASP PIM reduction was comparable to previous investigations.
Identifiants
pubmed: 31093941
doi: 10.1007/s11096-019-00846-y
pii: 10.1007/s11096-019-00846-y
doi:
Types de publication
Comparative Study
Controlled Clinical Trial
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
853-858Références
JAMA. 2005 Aug 10;294(6):716-24
pubmed: 16091574
Arch Intern Med. 2006 May 8;166(9):955-64
pubmed: 16682568
J Am Geriatr Soc. 2007 May;55(5):658-65
pubmed: 17493184
Lancet. 2007 Jul 14;370(9582):173-184
pubmed: 17630041
Arch Intern Med. 2009 May 11;169(9):894-900
pubmed: 19433702
Cochrane Database Syst Rev. 2016 Feb 20;2:CD008986
pubmed: 26895968
Br J Clin Pharmacol. 2016 Dec;82(6):1660-1673
pubmed: 27511835
Br J Clin Pharmacol. 2017 Mar;83(3):664-677
pubmed: 27670813
Drugs Aging. 2017 Feb;34(2):123-133
pubmed: 27915457
Int J Clin Pharm. 2018 Feb;40(1):15-19
pubmed: 29170978
JAMA Intern Med. 2018 Mar 1;178(3):375-382
pubmed: 29379953
Drugs Aging. 2018 May;35(5):375-377
pubmed: 29671214
Acta Clin Belg. 2019 Apr;74(2):75-81
pubmed: 29708056
Age Ageing. 2018 Sep 1;47(5):670-678
pubmed: 29893779
BMC Geriatr. 2018 Jul 3;18(1):155
pubmed: 29970005